Piermont Capital Management Inc. - SAGENT PHARMACEUTICALS INC ownership

SAGENT PHARMACEUTICALS INC's ticker is SGNT and the CUSIP is 786692103. A total of 136 filers reported holding SAGENT PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Piermont Capital Management Inc. ownership history of SAGENT PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2016$1,412,000
-36.2%
116,005
-16.6%
0.45%
-36.0%
Q4 2015$2,212,000
+2.8%
139,020
-1.0%
0.70%
+0.1%
Q3 2015$2,152,000
-36.0%
140,360
+1.4%
0.70%
-30.8%
Q2 2015$3,364,000
+24.2%
138,380
+18.8%
1.02%
+23.0%
Q1 2015$2,709,000
+661.0%
116,520
+722.3%
0.82%
+549.6%
Q4 2014$356,00014,1700.13%
Other shareholders
SAGENT PHARMACEUTICALS INC shareholders Q1 2016
NameSharesValueWeighting ↓
Timpani Capital Management LLC 110,215$2,248,0001.32%
Healthcare Value Capital, LLC 73,822$1,506,0001.32%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,014,863$20,703,0000.96%
Perimeter Capital Partners, LLC 248,893$5,077,0000.94%
Tekla Capital Management LLC 270,031$5,509,0000.61%
SECTORAL ASSET MANAGEMENT INC 564,325$11,512,0000.55%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 168,268$3,432,0000.35%
MENTA CAPITAL LLC 30,480$622,0000.32%
KOPP INVESTMENT ADVISORS LLC 39,934$815,0000.30%
Broadfin Capital, LLC 68,300$1,393,0000.25%
View complete list of SAGENT PHARMACEUTICALS INC shareholders